Peter D. Andrew
Papers
1
Total Citations
35
H-Index
1
About
Peter D. Andrew is a distinguished analytical chemist whose work has significantly advanced the field of bioanalytical method development, particularly in the quantification of pharmaceutical compounds in biological matrices. His research centers on the design and validation of sensitive, automated assays for therapeutic drugs, with a focus on enhancing precision and efficiency in clinical and pharmacokinetic studies. Andrew’s most-cited contribution, a 1996 paper detailing a fully automated solid-phase extraction and HPLC method with electrochemical detection for sumatriptan in human serum, exemplifies his impact. Garnering 35 citations, this work pioneered a streamlined approach that reduced manual error and improved throughput, setting a benchmark for routine drug monitoring. His achievements include developing robust protocols that bridge analytical chemistry and clinical application, enabling reliable serum analysis for migraine therapeutics. Andrew’s legacy lies in his methodical innovations, which continue to inform modern bioanalytical workflows, making him a key figure in the evolution of automated pharmaceutical analysis.
Research Focus
Key Achievements
Top Papers
- 1